本文已被:浏览 319次 下载 183次
Received:September 18, 2025 Published Online:August 25, 2026
Received:September 18, 2025 Published Online:August 25, 2026
中文摘要: 目的 建立基于空腹血糖(FPG)、糖化血红蛋白(HbA1C)、糖化白蛋白(GA)、空腹胰岛素(FINS)的多指标动态监测系统,探索妊娠期糖尿病(GDM)患者产后2型糖尿病(T2DM)高危人群的早期识别方法。方法 采用前瞻性队列研究设计,纳入2022年1月至2023年6月在西北妇女儿童医院分娩的345例GDM患者,完成12个月随访者312例。分别于产后6~12周、6个月、12个月检测FPG、HbA1C、GA、FINS,同时收集人口学特征、妊娠期相关指标及新生儿情况。采用重复测量方差分析评估各指标的动态变化规律,多因素logistic 回归分析产后T2DM的危险因素,建立多指标联合预测模型并评估其预测效能。结果 产后6个月T2DM发生率为8.3%(26/312),产后12个月发生率为16.7%(52/312)。根据产后12个月是否发生T2DM将312例患者分为产后T2DM组(n=52)和非产后 T2DM 组(n=260)。产后 T2DM 组在年龄、孕前身体质量指数(BMI)、产后 6 个月 BMI、T2DM 家族史、GDM 诊断孕周、≤24 周诊断 GDM、妊娠期需胰岛素治疗比例、新生儿体质量、巨大儿发生率等方面与非产后T2DM组差异均有统计学意义(P<0.05)。FPG、HbA1C、GA在产后T2DM组产后6~12周至产后12个月均呈持续上升趋势:FPG 从(5.8±0.9)mmol/L 升至(7.4±1.5)mmol/L,HbA1C 从 5.9%±0.9%升至 7.0%±1.2%,GA 从 16.2%±2.9%升至19.0%±3.7%,FINS仅整体组间水平存在差异(P<0.05);而以上指标在非产后T2DM组均保持相对稳定(P>0.05)。多因素 logistic 分析显示,产后 6~12 周 FPG≥5.6 mmol/L(OR=3.888,95%CI:1.868~8.093)、HbA1C≥
5.7%(OR=3.640,95%CI:1.718~7.711)、GA≥15.5%(OR=2.809,95%CI:1.313~6.010)是产后 T2DM 发生的独立危险因素(P<0.01)。FPG+HbA1C+GA三指标联合监测预测产后T2DM的受试者工作特征曲线下面积达0.863,模型拟合度佳。结论 基于FPG、HbA1C、GA的三指标联合动态监测系统能够有效识别GDM患者发生产后T2DM的高危人群,在产后6~12周即可实施风险评估,为早期干预提供参考依据。
Abstract:Objective To establish a multi-indicator dynamic monitoring system based on fasting plasma glucose(FPG),glycated hemoglobin(HbA1C),glycated albumin(GA),and fasting insulin(FINS),and to explore an early identification method for high-risk groups of postpartum type 2 diabetes mellitus(T2DM)among patients with gestational diabetes mellitus(GDM). Methods A prospective cohort study design was adopted,including 345 GDM patients who gave birth at Northwest Women and Children's Hospital from January 2022 to June 2023,of whom 312 completed a 12-month follow-up. FPG,HbA1C,GA,and FINS were measured at 6-12 weeks,6 months,and 12 months postpartum,respectively,while demographic characteristics,pregnancy-related indicators,and neonatal conditions were also collected. Repeated measures analysis of variance was used to evaluate the dynamic changes of each indicator over time,multivariate logistic regression was performed to identify risk factors for postpartum T2DM,and a multi-indicator joint prediction model was constructed and its predictive performance was evaluated. Results The incidence of T2DM was 8.3%(26/312)at 6 months postpartum and 16.7%(52/312)at 12 months postpartum. Based on the occurrence of T2DM at 12 months postpartum, the 312 patients were divided into a postpartum T2DM group(n=52)and a non-postpartum T2DM group(n=260). Compared with the non-postpartum T2DM group ,the postpartum T2DM group showed statistically significant differences in age,pre? pregnancy body mass index(BMI),postpartum 6-month BMI,family history of T2DM,gestational week at GDM diagnosis,GDM diagnosed before 24 weeks,proportion requiring insulin treatment during pregnancy,neonatal birth weight,and incidence of macrosomia(P<0.05). FPG,HbA1C,and GA showed a continuous upward trend in the postpartum T2DM group from 6 to 12 weeks postpartum through 12 months postpartum:FPG rose from(5.8±0.9)mmol/L to(7.4±1.5)mmol/L,HbA1C rose from 5.9%±0.9% to 7.0%±1.2%,and GA rose from 16.2%±2.9% to 19.0±3.7%. FINS showed a difference only in overall group levels(P<0.05);whereas the above indicators remained relatively stable in the non postpartum T2DM group(P>0.05). Multivariate logistic analysis revealed that,at 6-12 weeks postpartum,FPG≥5.6 mmol/L(OR=3.888,95%CI: 1.868-8.093),HbA1C≥5.7%(OR=3.640,95%CI: 1.718-7.711),GA≥15.5%(OR=2.809,95%CI:1.313-6.010)were independent risk factors for the development of postpartum T2DM(P<0.01). The combination monitoring of FPG+HbA1C+GA yielded an area under receiver operating characteristic curve of 0.863 for predicting postpartum T2DM,with good model fit. Conclusion The three-indicator dynamic monitoring system based on FPG,HbA1C,and GA can effectively identify high-risk individuals among GDM patients who are likely to develop postpartum T2DM,allowing risk assessment to be implemented as early as 6-12 weeks postpartum,and providing a reference basis for early intervention.
keywords: Gestational diabetes mellitus Postpartum diabetes Risk factors Early identification Glycemic metabolism indicator Dynamic monitoring
文章编号: 中图分类号:R587.1 文献标志码:A
基金项目:陕西省重点研发计划项目(2021SF-330)
| Author Name | Affiliation |
| SHI Xixi,XIE Yun,ZHANG Xiaofei,WU Dongna,GUO Liang | Northwest Women and Children's Hospital Medical Laboratory Center,Xi'an,Shannxi 710061,China |
| Author Name | Affiliation |
| SHI Xixi,XIE Yun,ZHANG Xiaofei,WU Dongna,GUO Liang | Northwest Women and Children's Hospital Medical Laboratory Center,Xi'an,Shannxi 710061,China |
引用文本:
